Che Guo-Wei, Zhou Qing-Hua, Zhu Wen, Wang Yan-Ping, Qin Yang, Liu Lun-Xu, Chen Xiao-He, Sun Yi-Lin, Sun Ze-Fang
Sichuan Provincial Key Laboratory of Lung Cancer Molecular Biology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P.R.China.
Ai Zheng. 2005 Mar;24(3):278-84.
BACKGROUND & OBJECTIVE: nm23-H1, a tumor metastasis suppressive gene, can reverse tumor metastasis phenotype. But the molecular mechanism of nm23-H1 in inhibiting or reversing metastasis of lung cancer is unclear. This study was to explore the molecular mechanism of nm23-H1 in reversing metastasis phenotype of lung cancer.
nm23-H1 gene and pLXSN were separately transfected into human lung cancer cell line L9981. Proliferation of L9981, L9981-pLXSN, and L9981-nm23-H1 cells was detected by MTT assay, cell invasive ability was detected by modified Boyden chamber. Tumorigenesis and experimental lung metastasis were determined in vivo. mRNA and protein levels of beta-catenin, E-Cadherin, CD44S, CD44V6, matrix metalloproteinase-2 (MMP-2), tissue inhibitor of metalloproteinase-1 (TIMP-1), and vascular endothelial growth factor (VEGF) were detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot.
(1)Cell proliferation, clone formation, and invasive ability were significantly lower in L9981-nm23-H1 cells than in L9981 cells [(19.5+/-2.9)% vs. 100%, 10.3+/-0.7 vs. 21.7+/-1.3, 31.0+/-3.0 vs. 151.0+/-6.3, P<0.01]. (2) The inhibitory rate of tumorigenesis of nude mice was significantly higher in L8891-nm23-H1 group than in L9981 group (85.6% vs. 0%, P<0.001)u the lung metastatic rate was significantly lower in L9981-nm23-H1 group than in L9981 group (0% vs. 100%, P<0.001). (3)nm23-H1 up-regulated mRNA and protein levels of beta-catenin, E-Cadherin, and TIMP-1, and down-regulated levels of MMP-2, CD44V6, and VEGF (P<0.01). (4) nm23-H1 up-regulated mRNA level of CD44s, protein level of CD44s didn't change (P>0.05).
nm23-H1 gene can reverse malignant and metastatic phenotype of L9981 cells through regulating the expressions of lung cancer metastasis-related genes.
nm23-H1是一种肿瘤转移抑制基因,可逆转肿瘤转移表型。但nm23-H1抑制或逆转肺癌转移的分子机制尚不清楚。本研究旨在探讨nm23-H1逆转肺癌转移表型的分子机制。
将nm23-H1基因和pLXSN分别转染入人肺癌细胞系L9981。采用MTT法检测L9981、L9981-pLXSN和L9981-nm23-H1细胞的增殖情况,采用改良Boyden小室检测细胞侵袭能力。在体内测定肿瘤发生和实验性肺转移情况。采用逆转录-聚合酶链反应(RT-PCR)和蛋白质印迹法检测β-连环蛋白、E-钙黏蛋白、CD44S、CD44V6、基质金属蛋白酶-2(MMP-2)、金属蛋白酶组织抑制剂-1(TIMP-1)和血管内皮生长因子(VEGF)的mRNA和蛋白水平。
(1)L9981-nm23-H1细胞的细胞增殖、克隆形成和侵袭能力均显著低于L9981细胞[(19.5±2.9)%对100%,10.3±0.7对21.7±1.3,31.0±3.0对151.0±6.3,P<0.01]。(2)L9981-nm23-H1组裸鼠肿瘤发生抑制率显著高于L9981组(85.6%对0%,P<0.001);L9981-nm23-H1组肺转移率显著低于L9981组(0%对100%,P<0.001)。(3)nm23-H1上调β-连环蛋白、E-钙黏蛋白和TIMP-1的mRNA和蛋白水平,下调MMP-2、CD44V6和VEGF的水平(P<0.01)。(4)nm23-H1上调CD44s的mRNA水平,CD44s的蛋白水平未改变(P>0.05)。
nm23-H1基因可通过调节肺癌转移相关基因的表达逆转L9981细胞的恶性和转移表型。